{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T20:30:39Z","timestamp":1787085039052,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.acra.2026.07.062","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T20:08:42Z","timestamp":1787083722000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early Prediction Of Treatment Response To Neoadjuvant Chemotherapy Based On Pre-treatment Ultrasound Radiomics of HER2-positive Breast Cancer Patients by Radiomics-based Model: A Dual-center Retrospective Study"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0124-6806","authenticated-orcid":false,"given":"Li-wen","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-ling","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-zhen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-lei","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-pei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0607-6044","authenticated-orcid":false,"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acra.2026.07.062_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.03.042","article-title":"Landscape of neoadjuvant therapy in HER2-positive breast cancer: a systematic review and network meta-analysis","volume":"190","author":"Villacampa","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.acra.2026.07.062_bib2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/ERC-18-0029","article-title":"Impact of hormone receptor status on the efficacy of HER2-targeted treatment","volume":"25","author":"Zhao","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.acra.2026.07.062_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.101965","article-title":"HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis","volume":"84","author":"Schettini","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.acra.2026.07.062_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10549-020-05599-1","article-title":"Complete pathologic response rate to neoadjuvant chemotherapy increases with increasing HER2\/CEP17 ratio in HER2 overexpressing breast cancer: analysis of the National Cancer Database (NCDB)","volume":"181","author":"Greenwell","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.acra.2026.07.062_bib5","doi-asserted-by":"crossref","first-page":"e390","DOI":"10.1016\/S1470-2045(19)30158-5","article-title":"Changing frameworks in treatment sequencing of triple-negative and HER2-positive, early-stage breast cancers","volume":"20","author":"Pusztai","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.acra.2026.07.062_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11864-021-00879-4","article-title":"Optimal management for residual disease following neoadjuvant systemic therapy","volume":"22","author":"Foldi","year":"2021","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.acra.2026.07.062_bib7","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1200\/JCO.2012.45.0940","article-title":"Response-guided neoadjuvant chemotherapy for breast cancer","volume":"31","author":"Von Minckwitz","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.acra.2026.07.062_bib8","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1200\/JCO.2013.51.0313","article-title":"Insight or confusion: survival after response-guided neoadjuvant chemotherapy in breast cancer","volume":"31","author":"Telli","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.acra.2026.07.062_bib9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10549-017-4254-0","article-title":"MRI predicts pathologic complete response in HER2-positive breast cancer after neoadjuvant chemotherapy","volume":"164","author":"Van Ramshorst","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.acra.2026.07.062_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13058-022-01580-6","article-title":"An integrated deep learning model for the prediction of pathological complete response to neoadjuvant chemotherapy with serial ultrasonography in breast cancer patients: a multicentre, retrospective study","volume":"24","author":"Wu","year":"2022","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.acra.2026.07.062_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.breast.2018.02.028","article-title":"Ultrasound-based prediction of pathologic response to neoadjuvant chemotherapy in breast cancer patients","volume":"39","author":"Baumgartner","year":"2018","journal-title":"Breast"},{"key":"10.1016\/j.acra.2026.07.062_bib12","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1007\/s11547-021-01389-x","article-title":"A deep look into radiomics","volume":"126","author":"Scapicchio","year":"2021","journal-title":"Radiol Med"},{"key":"10.1016\/j.acra.2026.07.062_bib13","doi-asserted-by":"crossref","first-page":"38S","DOI":"10.2967\/jnumed.118.220582","article-title":"Radiomics: data are also images","volume":"60","author":"Hatt","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.acra.2026.07.062_bib14","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.7150\/thno.30309","article-title":"The applications of radiomics in precision diagnosis and treatment of oncology: opportunities and challenges","volume":"9","author":"Liu","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.acra.2026.07.062_bib15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1148\/radiol.212873","article-title":"Development and validation of multiparametric mri-based radiomics models for preoperative risk stratification of endometrial cancer","volume":"305","author":"Lefebvre","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2026.07.062_bib16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1053\/j.semnuclmed.2019.06.005","article-title":"Radiomics analysis for clinical decision support in nuclear medicine","volume":"49","author":"Ibrahim","year":"2019","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.acra.2026.07.062_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clbc.2019.06.015","article-title":"Imaging and clinicopathologic features associated with pathologic complete response in HER2-positive breast cancer receiving neoadjuvant chemotherapy with dual HER2 blockade","volume":"20","author":"Yoon","year":"2020","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.acra.2026.07.062_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10549-023-07057-0","article-title":"Ultrasound and clinicopathological characteristics-based model for prediction of pathologic response to neoadjuvant chemotherapy in HER2-positive breast cancer: a case-control study","volume":"202","author":"Sui","year":"2023","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.acra.2026.07.062_bib19","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","article-title":"User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability","volume":"31","author":"Yushkevich","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.acra.2026.07.062_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejca.2021.01.028","article-title":"Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer","volume":"147","author":"Jiang","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.acra.2026.07.062_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17142312","article-title":"Evaluating the effectiveness of neoadjuvant therapy in Her2-positive invasive breast cancer: a comprehensive analysis of 167 cases in Romania","volume":"17","author":"Pop","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.acra.2026.07.062_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102064","article-title":"Biomarkers for HER2-positive metastatic breast cancer: beyond hormone receptors","volume":"88","author":"Dieci","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.acra.2026.07.062_bib23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13046-016-0380-5","article-title":"First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?","volume":"35","author":"Fabi","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.acra.2026.07.062_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10549-017-4155-2","article-title":"Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients","volume":"163","author":"Goorts","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.acra.2026.07.062_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10549-024-07484-7","article-title":"Tumor infiltrating lymphocytes and change in tumor load on MRI to assess response and prognosis after neoadjuvant chemotherapy in breast cancer","volume":"209","author":"Janssen","year":"2025","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.acra.2026.07.062_bib26","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/SLA.0000000000002953","article-title":"The clinical significance of breast-only and node-only pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT): a review of 20,000 Breast Cancer Patients in the National Cancer Data Base (NCDB)","volume":"268","author":"Fayanju","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.acra.2026.07.062_bib27","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.acra.2026.07.062_bib28","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1158\/1078-0432.CCR-18-3190","article-title":"Radiomics of multiparametric MRI for pretreatment prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer: a multicenter study","volume":"25","author":"Liu","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.acra.2026.07.062_bib29","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jamaoncol.2016.2631","article-title":"The potential of radiomic-based phenotyping in precision medicine: a review","volume":"2","author":"Aerts","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.acra.2026.07.062_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.compmedimag.2022.102129","article-title":"Wasserstein-based texture analysis in radiomic studies","volume":"102","author":"Belkhatir","year":"2022","journal-title":"Comput Med Imaging Graph"},{"key":"10.1016\/j.acra.2026.07.062_bib31","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1102\/1470-7330.2013.0015","article-title":"Quantifying tumour heterogeneity with CT","volume":"13","author":"Ganeshan","year":"2013","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.acra.2026.07.062_bib32","article-title":"MRI-based quantification of intratumoral heterogeneity for predicting treatment response to neoadjuvant chemotherapy in breast cancer","volume":"308","author":"Shi","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2026.07.062_bib33","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1109\/TCYB.2017.2781709","article-title":"Feature-related searching control model for curve detection","volume":"49","author":"Zhang","year":"2019","journal-title":"IEEE Trans Cybern"},{"key":"10.1016\/j.acra.2026.07.062_bib34","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","article-title":"Radiomics: the bridge between medical imaging and personalized medicine","volume":"14","author":"Lambin","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.acra.2026.07.062_bib35","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1038\/ncomms5006","article-title":"Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach","volume":"5","author":"Aerts","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.acra.2026.07.062_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101562","article-title":"Early prediction of treatment response to neoadjuvant chemotherapy based on longitudinal ultrasound images of HER2-positive breast cancer patients by Siamese multi-task network: a multicentre, retrospective cohort study","volume":"52","author":"Liu","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.acra.2026.07.062_bib37","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.1158\/1078-0432.CCR-17-1038","article-title":"Radiomics analysis for evaluation of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer","volume":"23","author":"Liu","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.acra.2026.07.062_bib38","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomics: images are more than pictures, they are data","volume":"278","author":"Gillies","year":"2016","journal-title":"Radiology"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226005714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226005714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T20:08:48Z","timestamp":1787083728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633226005714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":38,"alternative-id":["S1076633226005714"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2026.07.062","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Prediction Of Treatment Response To Neoadjuvant Chemotherapy Based On Pre-treatment Ultrasound Radiomics of HER2-positive Breast Cancer Patients by Radiomics-based Model: A Dual-center Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2026.07.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Association of Academic Radiology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}